These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29891624)

  • 21. Ezetimibe + statin: insufficient benefit.
    Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eisen A; Cannon CP; Blazing MA; Bohula EA; Park JG; Murphy SA; White JA; Giugliano RP; Braunwald E;
    Eur Heart J; 2016 Dec; 37(48):3576-3584. PubMed ID: 27569841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
    Cannon CP; Giugliano RP; Blazing MA; Harrington RA; Peterson JL; Sisk CM; Strony J; Musliner TA; McCabe CH; Veltri E; Braunwald E; Califf RM;
    Am Heart J; 2008 Nov; 156(5):826-32. PubMed ID: 19061694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
    Blazing MA; Giugliano RP; Cannon CP; Musliner TA; Tershakovec AM; White JA; Reist C; McCagg A; Braunwald E; Califf RM
    Am Heart J; 2014 Aug; 168(2):205-12.e1. PubMed ID: 25066560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
    Giugliano RP; Wiviott SD; Blazing MA; De Ferrari GM; Park JG; Murphy SA; White JA; Tershakovec AM; Cannon CP; Braunwald E
    JAMA Cardiol; 2017 May; 2(5):547-555. PubMed ID: 28291866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
    Pesaro AE; Granger CB; Lopes RD
    Am Heart J; 2016 Feb; 172():42-4. PubMed ID: 26856214
    [No Abstract]   [Full Text] [Related]  

  • 27. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.
    Gryn SE; Hegele RA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1255-62. PubMed ID: 25920750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe: Likely to Be Beneficial For All.
    Herrington WG; Preiss D; Armitage J
    Circulation; 2018 Apr; 137(15):1583-1584. PubMed ID: 29632152
    [No Abstract]   [Full Text] [Related]  

  • 29. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME.
    Japaridze L; Sadunishvili M; Megreladze I
    Georgian Med News; 2016 Mar; (252):15-22. PubMed ID: 27119829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe-Statin Combination Therapy.
    Nußbaumer B; Glechner A; Kaminski-Hartenthaler A; Mahlknecht P; Gartlehner G
    Dtsch Arztebl Int; 2016 Jul; 113(26):445-53. PubMed ID: 27412989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
    Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letter].
    Poli A
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739-40. PubMed ID: 26667952
    [No Abstract]   [Full Text] [Related]  

  • 33. [The IMPROVE-IT trial].
    Menozzi A; Lina D; Urbinati S; Greco C
    G Ital Cardiol (Rome); 2015 Dec; 16(12):667-71. PubMed ID: 26667942
    [No Abstract]   [Full Text] [Related]  

  • 34. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Richard T; Lelubre C; Vanhaeverbeek M
    N Engl J Med; 2015 Oct; 373(15):1475-6. PubMed ID: 26444740
    [No Abstract]   [Full Text] [Related]  

  • 35. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Singh JS; Struthers AD; Lang CC
    N Engl J Med; 2015 Oct; 373(15):1476. PubMed ID: 26444741
    [No Abstract]   [Full Text] [Related]  

  • 36. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Cannon CP; Blazing MA; Braunwald E
    N Engl J Med; 2015 Oct; 373(15):1476-7. PubMed ID: 26444734
    [No Abstract]   [Full Text] [Related]  

  • 37. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Nunes JP
    N Engl J Med; 2015 Oct; 373(15):1475. PubMed ID: 26444739
    [No Abstract]   [Full Text] [Related]  

  • 38. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Patti G; Cavallari I
    N Engl J Med; 2015 Oct; 373(15):1474-5. PubMed ID: 26444738
    [No Abstract]   [Full Text] [Related]  

  • 39. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Silbernagel G; Baumgartner I; März W
    N Engl J Med; 2015 Oct; 373(15):1473. PubMed ID: 26444735
    [No Abstract]   [Full Text] [Related]  

  • 40. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Egom EE
    N Engl J Med; 2015 Oct; 373(15):1474. PubMed ID: 26444737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.